4//SEC Filing
AEOLUS PHARMACEUTICALS, INC. 4
Accession 0001223692-09-000023
CIK 0001261734operating
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 4:31 PM ET
Size
6.3 KB
Accession
0001223692-09-000023
Insider Transaction Report
Form 4
MCMANUS MICHAEL P
Chief Financial Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2009-07-10+90,000→ 90,000 totalExercise: $0.39Exp: 2019-07-10→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]Options will vest at a rate of 7,500 per month from the grant date for twelve months, provided that Michael McManus is an employee or consultant of Aeolus on the applicable vesting date. In the event of a sale of Aeolus, through a merger or otherwise, all of the options shall be fully vested and immediately exercisable.
Documents
Issuer
AEOLUS PHARMACEUTICALS, INC.
CIK 0001261734
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001261734
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 4:31 PM ET
- Size
- 6.3 KB